Annual EBIT
-$34.23 M
+$19.58 M+36.39%
December 31, 2023
Summary
- As of February 8, 2025, HOWL annual earnings before interest & taxes is -$34.23 million, with the most recent change of +$19.58 million (+36.39%) on December 31, 2023.
- During the last 3 years, HOWL annual EBIT has fallen by -$11.82 million (-52.78%).
- HOWL annual EBIT is now -244.49% below its all-time high of -$9.94 million, reached on December 31, 2019.
Performance
HOWL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$15.43 M
+$678.00 K+4.21%
September 30, 2024
Summary
- As of February 8, 2025, HOWL quarterly earnings before interest & taxes is -$15.43 million, with the most recent change of +$678.00 thousand (+4.21%) on September 30, 2024.
- Over the past year, HOWL quarterly EBIT has dropped by -$8.15 million (-111.85%).
- HOWL quarterly EBIT is now -296.22% below its all-time high of -$3.89 million, reached on March 31, 2020.
Performance
HOWL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$57.72 M
-$8.15 M-16.43%
September 30, 2024
Summary
- As of February 8, 2025, HOWL TTM earnings before interest & taxes is -$57.72 million, with the most recent change of -$8.15 million (-16.43%) on September 30, 2024.
- Over the past year, HOWL TTM EBIT has dropped by -$23.55 million (-68.92%).
- HOWL TTM EBIT is now -1382.25% below its all-time high of -$3.89 million, reached on March 31, 2020.
Performance
HOWL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HOWL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.4% | -111.8% | -68.9% |
| 3 y3 years | -52.8% | -41.1% | -7.3% |
| 5 y5 years | -244.5% | -41.1% | -7.3% |
HOWL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.4% | -272.4% | +13.7% | -68.9% | +6.9% |
| 5 y | 5-year | -244.5% | +36.4% | -296.2% | +13.7% | -1382.3% | +6.9% |
| alltime | all time | -244.5% | +36.4% | -296.2% | +13.7% | -1382.3% | +6.9% |
Werewolf Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.43 M(-4.2%) | -$57.72 M(+16.4%) |
| Jun 2024 | - | -$16.11 M(+6.0%) | -$49.57 M(+31.8%) |
| Mar 2024 | - | -$15.19 M(+38.2%) | -$37.61 M(+9.9%) |
| Dec 2023 | -$34.23 M(-36.4%) | -$10.99 M(+50.9%) | -$34.23 M(+0.2%) |
| Sep 2023 | - | -$7.28 M(+75.8%) | -$34.17 M(-13.3%) |
| Jun 2023 | - | -$4.14 M(-64.9%) | -$39.42 M(-21.5%) |
| Mar 2023 | - | -$11.81 M(+8.0%) | -$50.25 M(-6.6%) |
| Dec 2022 | -$53.81 M | -$10.93 M(-12.8%) | -$53.81 M(-11.4%) |
| Sep 2022 | - | -$12.54 M(-16.3%) | -$60.76 M(-2.0%) |
| Jun 2022 | - | -$14.97 M(-2.6%) | -$62.02 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$15.37 M(-14.1%) | -$58.00 M(+15.8%) |
| Dec 2021 | -$50.09 M(+123.6%) | -$17.88 M(+29.6%) | -$50.09 M(+26.5%) |
| Sep 2021 | - | -$13.79 M(+25.9%) | -$39.59 M(+24.3%) |
| Jun 2021 | - | -$10.96 M(+47.0%) | -$31.85 M(+22.7%) |
| Mar 2021 | - | -$7.45 M(+0.8%) | -$25.96 M(+15.9%) |
| Dec 2020 | -$22.40 M(+125.5%) | -$7.39 M(+22.1%) | -$22.40 M(+49.2%) |
| Sep 2020 | - | -$6.05 M(+19.5%) | -$15.01 M(+67.6%) |
| Jun 2020 | - | -$5.07 M(+30.1%) | -$8.96 M(+130.1%) |
| Mar 2020 | - | -$3.89 M | -$3.89 M |
| Dec 2019 | -$9.94 M | - | - |
FAQ
- What is Werewolf Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual EBIT year-on-year change?
- What is Werewolf Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly EBIT year-on-year change?
- What is Werewolf Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM EBIT year-on-year change?
What is Werewolf Therapeutics annual earnings before interest & taxes?
The current annual EBIT of HOWL is -$34.23 M
What is the all time high annual EBIT for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual earnings before interest & taxes is -$9.94 M
What is Werewolf Therapeutics annual EBIT year-on-year change?
Over the past year, HOWL annual earnings before interest & taxes has changed by +$19.58 M (+36.39%)
What is Werewolf Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of HOWL is -$15.43 M
What is the all time high quarterly EBIT for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly earnings before interest & taxes is -$3.89 M
What is Werewolf Therapeutics quarterly EBIT year-on-year change?
Over the past year, HOWL quarterly earnings before interest & taxes has changed by -$8.15 M (-111.85%)
What is Werewolf Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of HOWL is -$57.72 M
What is the all time high TTM EBIT for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM earnings before interest & taxes is -$3.89 M
What is Werewolf Therapeutics TTM EBIT year-on-year change?
Over the past year, HOWL TTM earnings before interest & taxes has changed by -$23.55 M (-68.92%)